Pfizer Inc. (PFE)
29.44
+0.23
(+0.79%)
USD |
NYSE |
Oct 15, 16:00
29.45
+0.01
(+0.03%)
Pre-Market: 06:46
Pfizer SG&A Expense (TTM) : 13.72B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.72B |
| March 31, 2026 | 13.72B |
| December 31, 2025 | 13.79B |
| September 30, 2025 | 13.91B |
| June 30, 2025 | 13.96B |
| March 31, 2025 | 14.27B |
| December 31, 2024 | 14.73B |
| September 30, 2024 | 15.03B |
| June 30, 2024 | 15.07B |
| March 31, 2024 | 14.85B |
| December 31, 2023 | 14.77B |
| September 30, 2023 | 14.84B |
| June 30, 2023 | 14.95B |
| March 31, 2023 | 14.50B |
| December 31, 2022 | 13.68B |
| September 30, 2022 | 13.14B |
| June 30, 2022 | 12.64B |
| March 31, 2022 | 12.52B |
| December 31, 2021 | 12.70B |
| September 30, 2021 | 12.35B |
| June 30, 2021 | 12.11B |
| March 31, 2021 | 11.85B |
| December 31, 2020 | 11.61B |
| September 30, 2020 | 12.10B |
| June 30, 2020 | 12.70B |
| Date | Value |
|---|---|
| March 31, 2020 | 13.55B |
| December 31, 2019 | 14.35B |
| September 30, 2019 | 14.12B |
| June 30, 2019 | 14.35B |
| March 31, 2019 | 14.38B |
| December 31, 2018 | 14.46B |
| September 30, 2018 | 15.00B |
| June 30, 2018 | 15.01B |
| March 31, 2018 | 14.90B |
| December 31, 2017 | 14.79B |
| September 30, 2017 | 14.66B |
| June 30, 2017 | 14.72B |
| March 31, 2017 | 14.76B |
| December 31, 2016 | 14.84B |
| September 30, 2016 | 15.46B |
| June 30, 2016 | 15.17B |
| March 31, 2016 | 15.09B |
| December 31, 2015 | 14.81B |
| September 30, 2015 | 13.74B |
| June 30, 2015 | 14.03B |
| March 31, 2015 | 14.16B |
| December 31, 2014 | 14.10B |
| September 30, 2014 | 14.27B |
| June 30, 2014 | 14.11B |
| March 31, 2014 | 14.18B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Johnson & Johnson | 19.22B |
| Eli Lilly & Co. | 12.24B |
| Merck & Co., Inc. | 11.14B |
| Bristol Myers Squibb Co. | 7.413B |
| Viatris, Inc. | 3.981B |